|
DUSP11 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.178000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.003100E-03 |
| Normal-vs-Stage2 |
8.895200E-01 |
| Normal-vs-Stage3 |
6.941800E-01 |
| Normal-vs-Stage4 |
3.737200E-01 |
| Stage1-vs-Stage2 |
2.227600E-01 |
| Stage1-vs-Stage3 |
7.498400E-03 |
| Stage1-vs-Stage4 |
1.344940E-03 |
| Stage2-vs-Stage3 |
7.186400E-01 |
| Stage2-vs-Stage4 |
5.199400E-01 |
| Stage3-vs-Stage4 |
6.639000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.502400E-01 |
| Normal-vs-AfricanAmerican |
3.730800E-01 |
| Normal-vs-Asian |
5.415400E-01 |
| Caucasian-vs-AfricanAmerican |
9.624100E-02 |
| Caucasian-vs-Asian |
9.723000E-01 |
| AfricanAmerican-vs-Asian |
4.337800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.937200E-01 |
| Normal-vs-Female |
6.977300E-03 |
| Male-vs-Female |
2.857000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.334790E-01 |
| Normal-vs-Age(41-60Yrs) |
2.563800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.868590E-01 |
| Normal-vs-Age(81-100Yrs) |
6.566600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.989900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.217800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.653000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.863000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.639000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.902200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.023500E-03 |
| Normal-vs-Grade 2 |
1.496170E-03 |
| Normal-vs-Grade 3 |
7.658200E-01 |
| Normal-vs-Grade 4 |
4.922600E-03 |
| Grade 1-vs-Grade 2 |
4.675800E-01 |
| Grade 1-vs-Grade 3 |
7.088400E-02 |
| Grade 1-vs-Grade 4 |
1.139870E-03 |
| Grade 2-vs-Grade 3 |
2.361200E-03 |
| Grade 2-vs-Grade 4 |
1.05210000045375E-07 |
| Grade 3-vs-Grade 4 |
2.075500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.22109988787145E-10 |
| Normal-vs-ccB subtype |
2.961300E-04 |
| ccA subtype-vs-ccB subtype |
1.62447832963153E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.989010E-01 |
| Normal-vs-N1 |
1.475660E-03 |
| N0-vs-N1 |
1.697370E-03 |
|
|
